Gavi’s purchase puts the total number of vaccines pledged for Africa’s mpox response at more than 4.1 million. European ...

The global vaccine alliance Gavi says it will buy 500,000 doses of vaccine against mpox to fight outbreaks of the disease in ...

LONDON (Reuters) -Bavarian Nordic said on Thursday its mpox vaccine was approved by the EU's drug regulator for use in ...

(RTTNews) - Bavarian Nordic A/S (BAVA) Thursday said that the European Commission has adopted the Committee for Medicinal Products for Human Use (CHMP) recommendation for the approval of a type II ...

Bavarian Nordic's mpox vaccine has gained approval for use in adolescents by the EU's drug regulator. This move is seen as ...

Bavarian Nordic A/S, one of the only companies with a vaccine approved for mpox, has received regulatory approval in Europe ...

MVA-BN approved for use against mpox and smallpox in adolescents 12-17 years of age after expedited review with EMARepresents ...

Gavi (the Global Alliance for Vaccines and Immunization) has entered an advance purchase agreement with Bavarian Nordic to ...

The European Commission has approved Bavarian Nordic's (OTCPK:BVNRY)(OTCPK:BVNKF) mpox shot for adolescents between 12 and 17 ...

Gavi, the Vaccine Alliance and the U.K. government ordered a combined 650,000 doses of Bavarian Nordic’s Jynneos mpox vaccine ...

LONDON, Sept 19 (Reuters) - The EU's drug regulator has approved Bavarian Nordic's (BAVA.CO), opens new tab mpox vaccine for ...

Denmark-based Bavarian Nordic and Gavi, the Vaccine Alliance yesterday announced an advance purchase agreement (APA) to ...